Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 12

1.

Application of a MYC degradation screen identifies sensitivity to CDK9 inhibitors in KRAS-mutant pancreatic cancer.

Blake DR, Vaseva AV, Hodge RG, Kline MP, Gilbert TSK, Tyagi V, Huang D, Whiten GC, Larson JE, Wang X, Pearce KH, Herring LE, Graves LM, Frye SV, Emanuele MJ, Cox AD, Der CJ.

Sci Signal. 2019 Jul 16;12(590). pii: eaav7259. doi: 10.1126/scisignal.aav7259.

2.

Induction of a chronic disease state in patients with smoldering or indolent multiple myeloma by targeting interleukin 1{beta}-induced interleukin 6 production and the myeloma proliferative component.

Lust JA, Lacy MQ, Zeldenrust SR, Dispenzieri A, Gertz MA, Witzig TE, Kumar S, Hayman SR, Russell SJ, Buadi FK, Geyer SM, Campbell ME, Kyle RA, Rajkumar SV, Greipp PR, Kline MP, Xiong Y, Moon-Tasson LL, Donovan KA.

Mayo Clin Proc. 2009 Feb;84(2):114-22. doi: 10.4065/84.2.114.

3.

R-(-)-gossypol (AT-101) activates programmed cell death in multiple myeloma cells.

Kline MP, Rajkumar SV, Timm MM, Kimlinger TK, Haug JL, Lust JA, Greipp PR, Kumar S.

Exp Hematol. 2008 May;36(5):568-76. doi: 10.1016/j.exphem.2008.01.003. Epub 2008 Mar 17.

4.

ABT-737, an inhibitor of Bcl-2 family proteins, is a potent inducer of apoptosis in multiple myeloma cells.

Kline MP, Rajkumar SV, Timm MM, Kimlinger TK, Haug JL, Lust JA, Greipp PR, Kumar S.

Leukemia. 2007 Jul;21(7):1549-60. Epub 2007 Apr 26.

PMID:
17460700
5.

Thymoglobulin targets multiple plasma cell antigens and has in vitro and in vivo activity in multiple myeloma.

Timm MM, Kimlinger TK, Haug JL, Kline MP, Greipp PR, Rajkumar SV, Kumar SK.

Leukemia. 2006 Oct;20(10):1863-9. Epub 2006 Aug 17.

PMID:
16932343
6.

Identification of two groups of smoldering multiple myeloma patients who are either high or low producers of interleukin-1.

Xiong Y, Donovan KA, Kline MP, Gornet MK, Moon-Tasson LL, Lacy MQ, Dispenzieri A, Gertz MA, Greipp PR, Lust JA.

J Interferon Cytokine Res. 2006 Feb;26(2):83-95.

PMID:
16487028
7.

Elevated serum B-lymphocyte stimulator levels in patients with familial lymphoproliferative disorders.

Novak AJ, Grote DM, Ziesmer SC, Kline MP, Manske MK, Slager S, Witzig TE, Shanafelt T, Call TG, Kay NE, Jelinek DF, Cerhan JR, Gross JA, Harder B, Dillon SR, Ansell SM.

J Clin Oncol. 2006 Feb 20;24(6):983-7. Epub 2006 Jan 23.

PMID:
16432079
8.

Follicle-stimulating hormone promotes histone H3 phosphorylation on serine-10.

DeManno DA, Cottom JE, Kline MP, Peters CA, Maizels ET, Hunzicker-Dunn M.

Mol Endocrinol. 1999 Jan;13(1):91-105.

PMID:
9892015
9.

Contrast in cytokine expression between patients with monoclonal gammopathy of undetermined significance or multiple myeloma.

Donovan KA, Lacy MQ, Kline MP, Ahmann GJ, Heimbach JK, Kyle RA, Lust JA.

Leukemia. 1998 Apr;12(4):593-600.

11.

The heat-shock response: regulation and function of heat-shock proteins and molecular chaperones.

Morimoto RI, Kline MP, Bimston DN, Cotto JJ.

Essays Biochem. 1997;32:17-29. Review.

PMID:
9493008
12.

Isolation of an mRNA encoding a soluble form of the human interleukin-6 receptor.

Lust JA, Donovan KA, Kline MP, Greipp PR, Kyle RA, Maihle NJ.

Cytokine. 1992 Mar;4(2):96-100.

PMID:
1633265

Supplemental Content

Loading ...
Support Center